Appointment
Enterprise Therapeutics: Vital service
Most recently, he was Chief Operating Officer at Dezima, which was acquired by Amgen in September 2015. He also led the team for Receptors and Channel Drug Discovery at BioFocus. Ford holds a BSc and a PhD in biochemistry and molecular biology from the University of Leeds.